Skip to content
Screener
Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$25.43M+42.6%$22.59M+165%$14.2M+260%$18.44M+245%$17.83M+556%
$472K+31.8%$468K+35.7%$467K+16.8%$384K-3.8%$358K-16.7%
$11.64M+31.1%$10.06M+29.8%$10.24M+23.3%$10.14M+29.6%$8.88M+20.5%
$47.2M+68.0%$50.2M+125%$53.89M+187%$33.68M$28.09M+444%
$663K+302%$161K+62.6%$633K+228%$671K$165K
-$73.58M-1,795%-$31.92M+38.1%-$70.81M-208%-$62.76M-889%-$3.88M+91.7%
$12.11M+13.2%$6.07M+119%$7.66M+258%$11.9M+77.9%$10.7M
$24.36M+192%-$9.26M-111%-$17.18M-807%$34.91M+183%
$46.53M+66.6%$50.04M+125%$53.26M+187%$33.01M$27.93M+440%

FAQ

How much cash does Kiniksa Pharmaceuticals International, plc generate?
Kiniksa Pharmaceuticals International, plc (KNSA) generated $185.0M in operating cash flow over the trailing twelve months.
What is Kiniksa Pharmaceuticals International, plc's free cash flow?
After $2.1M of capital expenditures, Kiniksa Pharmaceuticals International, plc's free cash flow was $182.8M over the trailing twelve months, up 166.0% year over year.
Where does Kiniksa Pharmaceuticals International, plc's cash flow data come from?
Every line is extracted from Kiniksa Pharmaceuticals International, plc's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.